CD8A and neoplasm: The rationale of combining DC vaccines with immunomodulatory drugs is strongly sustained by the study of Bulgarelli et al. that revealed an increase in CD8+ TIL following vaccination with autologous DCs loaded with tumor lysates, thus demonstrating that DC vaccine sustains a T-cell inflamed TME [174].